Results 1 to 10 of about 2,331 (158)

Efficacy of Der f 2/Zen 1-LAMP1 Plasmid-Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof-of-Concept Study. [PDF]

open access: yesVet Dermatol
Background: DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP). Objectives: This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD ...
Bizikova P   +6 more
europepmc   +2 more sources

Vaccines of the basic scheme for the first year of life late in northeastern brazilian city

open access: yesRevista de Pesquisa Cuidado é Fundamental Online, 2015
Objetivo:Avaliar o cumprimento do calendário básico de vacinação de crianças no primeiro ano de vida assistidas por equipes da Estratégia Saúde da Família em um município do nordeste brasileiro.
Conceição Ceanny Formiga Sinval Cavalcante   +5 more
doaj   +7 more sources

Intenção e Atitudes de estudantes universitários/as brasileiros/as face à vacina COVID-19

open access: yesRevista de Estudios e Investigación en Psicología y Educación, 2023
A vacinação é uma importante medida preventiva para reduzir a pandemia da COVID-19 e o seu impacto em termos de morbilidade, mortalidade e hospitalizações.
Regina Alves   +2 more
doaj   +1 more source

Vacinas contra varicela e vacina quádrupla viral [PDF]

open access: yesJornal de Pediatria, 2006
OBJETIVOS: Apresentar uma revisao atualizada sobre os estudos de eficacia, eventos adversos e esquema vacinal da vacina contra varicela e a nova apresentacao combinada com a vacina contra sarampo, caxumba e rubeola. FONTES DOS DADOS: Revisao bibliografica utilizando a base de dados MEDLINE e LILACS no periodo de 1999 a 2006. SINTESE DOS DADOS: A vacina
Bricks, Lucia Ferro   +2 more
openaire   +3 more sources

Vacina Já!

open access: yesRevista da Faculdade de Odontologia de Porto Alegre, 2021
Vacina Já!
D'Ávila, Otávio Pereira   +1 more
openaire   +6 more sources

Comparative complete scheme and booster effectiveness of COVID‐19 vaccines in preventing SARS‐CoV‐2 infections with SARS‐CoV‐2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case–case study based on electronic health records

open access: yesInfluenza and Other Respiratory Viruses, Volume 17, Issue 3, March 2023., 2023
Abstract Background Information on vaccine effectiveness in a context of novel variants of concern (VOC) emergence is of key importance to inform public health policies. This study aimed to estimate a measure of comparative vaccine effectiveness between Omicron (BA.1) and Delta (B.1.617.2 and sub‐lineages) VOC according to vaccination exposure (primary
Irina Kislaya   +26 more
wiley   +1 more source

Progression of Type 1 Diabetes: Circulating MicroRNA Expression Profiles Changes from Preclinical to Overt Disease

open access: yesJournal of Immunology Research, Volume 2022, Issue 1, 2022., 2022
Aims/Hypothesis. The role of microRNAs (miRNAs) in type 1 diabetes (T1D) pathogenesis and progression has been described but remains elusive. Objectives. To evaluate the potential biological involvement of miRNA expression in the immune response and beta cell function in T1D. Methods.We screened 377 serum miRNAs of 110 subjects divided into four groups:
Aritania Sousa Santos   +8 more
wiley   +1 more source

Transplantation programs facing lack of empirical evidence on SARS‐CoV‐2 vaccination: A society recommendation consensus update

open access: yesTransplant Infectious Disease, Volume 23, Issue 4, August 2021., 2021
Abstract Background Since phase III trials for the most prominent vaccines excluded immunocompromised or immunosuppressed patients, data on safety and efficacy of SARS‐CoV‐2 vaccines for recipients of solid organ transplantations are scarce. Aims Our study offers a synthesis of expert opinions aligned with available data addressing key questions of the
Nora Nevermann   +13 more
wiley   +1 more source

Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2‐Based Protein for Human Visceral Leishmaniasis Diagnosis

open access: yesJournal of Immunology Research, Volume 2021, Issue 1, 2021., 2021
Summary. Human visceral leishmaniasis (VL) is a major public health problem worldwide, leading to significant mortality rates if not properly treated and controlled. Precise identification of infected patients is essential to establish treatment and control measures.
Maria Marta Figueiredo   +17 more
wiley   +1 more source

DOENÇA DE AUJESZKY: PROTEÇÃO CONFERIDA POR TRÊS VACINAS INATIVADAS

open access: yesCiência Rural, 1994
RESUMO Foi testada a eficiência de três diferentes formulações de vacina contra a doença de Aujeszky (DA). A vacina I foi formulada com antígeno em óleo com emulsão simples; a vacina II em óleo, acrescida de coadjuvante de imunidade celular e a vacina ...
Alexandre da Rocha Gonçalves   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy